scholarly journals A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

2017 ◽  
Vol 116 (5) ◽  
pp. 568-574 ◽  
Author(s):  
J J Yang ◽  
Q Zhou ◽  
H H Yan ◽  
X C Zhang ◽  
H J Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Randomised Controlled Trial ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Controlled Trial ◽  
Small Cell ◽  
Phase Iii ◽  
Egfr Mutations ◽  
Small Cell Lung ◽  
Randomised Controlled

scholarly journals Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

The Lancet ◽  
2009 ◽  
Vol 374 (9687) ◽  
pp. 379-386 ◽  
Author(s):  
Kathy S Albain ◽  
R Suzanne Swann ◽  
Valerie W Rusch ◽  
Andrew T Turrisi ◽  
Frances A Shepherd ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Randomised Controlled Trial ◽  
Small Cell Lung Cancer ◽  
Surgical Resection ◽  
Cell Lung Cancer ◽  
Controlled Trial ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document